F/M Emerald Life Sciences Innovation ETF (LFSC)

Assets	$69.70M
Expense Ratio	0.54%
PE Ratio	n/a
Shares Out	2.36M
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	1,701
Open	29.99
Previous Close	29.96
Day's Range	29.92 - 30.03
52-Week Low	18.78
52-Week High	30.26
Beta	n/a
Holdings	36
Inception Date	Oct 31, 2024

About LFSC

Fund Home Page

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NASDAQ
• Ticker Symbol: LFSC
• ETF Provider: F/m Investments

Top 10 Holdings

48.14% of assets

Name	Symbol	Weight
Travere Therapeutics, Inc.	TVTX	6.87%
LivaNova PLC	LIVN	5.78%
TransMedics Group, Inc.	TMDX	5.18%
Cogent Biosciences, Inc.	COGT	4.70%
Soleno Therapeutics, Inc.	SLNO	4.68%
Nektar Therapeutics	NKTR	4.65%
Guardant Health, Inc.	GH	4.20%
RadNet, Inc.	RDNT	4.18%
Madrigal Pharmaceuticals, Inc.	MDGL	4.11%
BridgeBio Pharma, Inc.	BBIO	3.80%